Birdwatch Note Rating
2023-11-24 23:12:06 UTC - HELPFUL
Rated by Participant: E05CF18BE0E273EA8DDEA6CC63602F51E0B54DF4B03475FEFD0334F23A7033DF
Participant Details
Original Note:
Claim is false. In the trial the effectiveness of the vaccine for severe RSV in babies was 81.8%. The clinical trial efficacy & safety data is publicly available. The available data are insufficient to establish a causal relationship between preterm birth & the vaccine https://www.fda.gov/news-events/press-announcements/fda-approves-first-vaccine-pregnant-individuals-prevent-rsv-infants https://www.nejm.org/doi/10.1056/NEJMoa2216480 https://www.fda.gov/media/169361/download
All Note Details